Cargando…

A Structure‐Activity Relationship Study of Bimodal BODIPY‐Labeled PSMA‐Targeting Bioconjugates

The aim of this study was to identify a high‐affinity BODIPY peptidomimetic that targets the prostate‐specific membrane antigen (PSMA) as a potential bimodal imaging probe for prostate cancer. For the structure‐activity study, several BODIPY (difluoroboron dipyrromethene) derivatives with varying sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stemler, Tobias, Hoffmann, Caroline, Hierlmeier, Ina M., Maus, Stephan, Krause, Elmar, Ezziddin, Samer, Jung, Gregor, Bartholomä, Mark D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453963/ https://www.ncbi.nlm.nih.gov/pubmed/33905162 http://dx.doi.org/10.1002/cmdc.202100210

Ejemplares similares

Efficacy and Safety of [(225)Ac]Ac-PSMA-617 Augmented [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis
por: Rosar, Florian, et al.
Publicado: (2021)

Value of Combined PET Imaging with [(18)F]FDG and [(68)Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [(177)Lu]Lu-PSMA-617 RLT
por: Khreish, Fadi, et al.
Publicado: (2021)

Molecular imaging and biochemical response assessment after a single cycle of [(225)Ac]Ac-PSMA-617/[(177)Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [(177)Lu]Lu-PSMA-617 monotherapy
por: Rosar, Florian, et al.
Publicado: (2021)

Renal Safety of [(177)Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function
por: Rosar, Florian, et al.
Publicado: (2021)

Comparison of different methods for post-therapeutic dosimetry in [(177)Lu]Lu-PSMA-617 radioligand therapy
por: Rosar, Florian, et al.
Publicado: (2021)

Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of (64)Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates
por: Martin, Sebastian, et al.
Publicado: (2020)

Detection efficacy of [(89)Zr]Zr-PSMA-617 PET/CT in [(68)Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer
por: Rosar, Florian, et al.
Publicado: (2023)

Response Assessment and Prediction of Progression-Free Survival by (68)Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing (177)Lu-PSMA-617 Radioligand Therapy
por: Khreish, Fadi, et al.
Publicado: (2021)

Addition of Standard Enzalutamide Medication Shows Synergistic Effects on Response to [(177)Lu]Lu-PSMA-617 Radioligand Therapy in mCRPC Patients with Imminent Treatment Failure—Preliminary Evidence of Pilot Experience
por: Rosar, Florian, et al.
Publicado: (2022)

Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC
por: Rosar, Florian, et al.
Publicado: (2022)

Neuron-specific enolase has potential value as a biomarker for [(18)F]FDG/[(68)Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients
por: Rosar, Florian, et al.
Publicado: (2020)

177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)
por: Khreish, Fadi, et al.
Publicado: (2021)

Early molecular imaging response assessment based on determination of total viable tumor burden in [(68)Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [(177)Lu]Lu-PSMA-617 radioligand therapy
por: Rosar, Florian, et al.
Publicado: (2021)

[(89)Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates
por: Rosar, Florian, et al.
Publicado: (2022)

PSMA-Positive Follicular Thyroid Carcinoma Incidentally Detected by [(68)Ga]Ga-PSMA-11 PET/CT: Correlation with Immunohistology Confirms Neovascular PSMA-Expression
por: Rosar, Florian, et al.
Publicado: (2022)

Conjugated Polymer Nanoparticles for Label‐Free and Bioconjugate‐Recognized DNA Sensing in Serum
por: Bao, Biqing, et al.
Publicado: (2015)

Histologically Confirmed Testicular Metastasis Revealed by [(89)Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging
por: Rosar, Florian, et al.
Publicado: (2023)

Photoactivatable Fluorophore for Stimulated Emission Depletion (STED) Microscopy and Bioconjugation Technique for Hydrophobic Labels
por: Weber, Michael, et al.
Publicado: (2020)

Brain Delivery of Multifunctional Dendrimer Protein Bioconjugates
por: Moscariello, Pierpaolo, et al.
Publicado: (2018)

Covalent Linkage of BODIPY‐Photosensitizers to Anderson‐Type Polyoxometalates Using CLICK Chemistry
por: Cetindere, Seda, et al.
Publicado: (2021)

Fluorinated Boron-Dipyrromethene (BODIPY) Dyes: Bright and Versatile Probes for Surface Analysis
por: Hecht, Mandy, et al.
Publicado: (2013)

Solid-state emissive O-BODIPY dyes with bimodal emissions across red and near infrared region
por: El-Ali, H. A. Abdulhadi, et al.
Publicado: (2019)

Antiproliferative Activity of Functionalized Histidine‐derived Au(I) bis‐NHC Complexes for Bioconjugation
por: Jakob, Christian H. G., et al.
Publicado: (2020)

Bioorthogonal Turn‐On BODIPY‐Peptide Photosensitizers for Tailored Photodynamic Therapy
por: Linden, Greta, et al.
Publicado: (2020)

Synthesis and Properties of BODIPY Appended Tetraphenylethylene Scaffolds as Photoactive Arrays
por: Sample, Harry C., et al.
Publicado: (2021)

BODIPY-Labeled Estrogens for Fluorescence Analysis of Environmental Microbial Degradation
por: Felion, Celeste, et al.
Publicado: (2022)

Artificial bioconjugates with naturally occurring linkages: the use of phosphodiester
por: Shoji, Takao, et al.
Publicado: (2018)

BODIPY-based fluorescent liposomes with sesquiterpene lactone trilobolide
por: Škorpilová, Ludmila, et al.
Publicado: (2017)

Plasmonic Nanoparticles with Quantitatively Controlled Bioconjugation for Photoacoustic Imaging of Live Cancer Cells
por: Tian, Chao, et al.
Publicado: (2016)

Carbazole‐ and Fluorene‐Fused Aza‐BODIPYs: NIR Fluorophores with High Brightness and Photostability
por: Rappitsch, Tanja, et al.
Publicado: (2021)

Detection Efficacy of (68)Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience
por: Burgard, Caroline, et al.
Publicado: (2023)

Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation
por: Tsao, Kelvin K., et al.
Publicado: (2020)

Joint EANM/SNMMI procedure guideline for the use of (177)Lu-labeled PSMA-targeted radioligand-therapy ((177)Lu-PSMA-RLT)
por: Kratochwil, Clemens, et al.
Publicado: (2023)

Luminescent Bimetallic Ir(III)/Au(I) Peptide Bioconjugates as Potential Theranostic Agents
por: Luengo, Andrés, et al.
Publicado: (2020)

Two π‐Electrons Make the Difference: From BODIPY to BODIIM Switchable Fluorescent Dyes
por: Dolati, Hadi, et al.
Publicado: (2020)

Halogen‐Bonding Strapped Porphyrin BODIPY Rotaxanes for Dual Optical and Electrochemical Anion Sensing
por: Cheong Tse, Yuen, et al.
Publicado: (2021)

Repulsive bimodal atomic force microscopy on polymers
por: Gigler, Alexander M, et al.
Publicado: (2012)

Generalized Hertz model for bimodal nanomechanical mapping
por: Labuda, Aleksander, et al.
Publicado: (2016)

Synthesis and properties of novel star-shaped oligofluorene conjugated systems with BODIPY cores
por: Orofino-Pena, Clara, et al.
Publicado: (2014)

Rational design of boron-dipyrromethene (BODIPY) reporter dyes for cucurbit[7]uril
por: Alnajjar, Mohammad A, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_00h47ukq4a3f02evr0634epkik